COVID: BioNTech-Pfizer vaccine shows '100% efficacy' for young teens
Published
New clinical trial data shows "topline results" for kids between 12 to 15-years-old, Pfizer and BioNTech said. Vaccinating children will be crucial for stopping the pandemic and helping schools look more normal.
Full Article